Fergus Fleming
Fortuna: 14 422 $ al 31/05/2026
Fortuna: 14 422 $ al 31/05/2026
Fergus Fleming is currently the Director & Chief Technology Officer at Renalytix Plc.
Previously, he worked as the Managing Director at Ff Consulting Ltd. from 2014 to 2018.
He also served as the Head-Business Development at Oncomark Ltd. from 2016 to 2018.
Mr. Fleming completed his undergraduate degree at the National University of Ireland Galway.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
RENALYTIX PLC 0,14 % | 20/12/2024 | 594.481 ( 0,14 % ) | 14 422 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| RENALYTIX PLC | Director Técnico/Científico/I+D | 15/03/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
Ff Consulting Ltd. | Director Ejecutivo | 01/11/2018 |
Oncomark Ltd.
Oncomark Ltd. Medical SpecialtiesHealth Technology Operates as a diagnostics company that develops novel cancer biomarkers | Corporate Officer/Principal | 01/10/2018 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 4 |
|---|---|
Oncomark Ltd.
Oncomark Ltd. Medical SpecialtiesHealth Technology Operates as a diagnostics company that develops novel cancer biomarkers | Health Technology |
National University of Ireland Galway
National University of Ireland Galway Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Renalytix Plc
Renalytix Plc Packaged SoftwareTechnology Services Provides artificial intelligence for kidney disease | Technology Services |
Ff Consulting Ltd. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.